The 1st webinar was held at 9am PST on November 28, 2017 via a webinar portal of Sarcopenia -Education Series for Clinicians-, focusing on the latest knowledge about sarcopenia.
In the 1st webinar, Dr. John Morley, Professor and Division Chief of Geriatric Medicine and Endocrinology, Saint Louis University School of Medicine, who is a key opinion leader in an academic discussion about sarcopenia, had a talk on definitions of and practical diagnosis of sarcopenia. The video is now on SarcopeniaHelp.com.
To access the webcast at SarcopeniaHelp.com
Please see the attached flyer.
Inquiry about the webinar program
Dan Mueller, GM, AstaMed: email@example.com
Sarcopenia is a disease that leads to the progressive loss of skeletal muscle. In Sarcopenia, muscle mass decreases beyond the normal aging process because of inadequate lifestyle and other issues leading to decrease in muscle strength and/or physical performance, negatively impacting Quality of Life, mobility and independence, and even resulting in mortality. It has long been considered a part of aging that cannot be managed, even though it is estimated that sarcopenia affects approximately 45% of the U.S. senior population and exceeds $18 billion dollars in direct healthcare costs annually. Beginning October 1, 2016, sarcopenia was coded in the International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) under the code of M62.84.